Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device
MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ — Sparta Biomedical Inc., a privately held medical technology company, revolutionizing osteoarthritis treatment, is pleased to announce the close of a heavily oversubscribed convertible funding round. The company is thrilled to welcome new medtech and angel investors, along with participation from previous backers, reinforcing their unwavering belief in Sparta’s mission.
